How much funding has PHAGEPRO, INC. raised?

PHAGEPRO, INC. has raised $4.3M in total funding, most recently a Venture Round.

Who are PHAGEPRO, INC.'s investors?

PHAGEPRO, INC.'s investors include National Institutes of Health.

When was PHAGEPRO, INC. founded?

PHAGEPRO, INC. was founded in 2019.

Where is PHAGEPRO, INC. headquartered?

PHAGEPRO, INC. is headquartered in MANSFIELD, Massachusetts, United States.

What industry is PHAGEPRO, INC. in?

PHAGEPRO, INC. operates in Biotech, Healthcare.

How many employees does PHAGEPRO, INC. have?

PHAGEPRO, INC. has 1-10 employees.

PHAGEPRO, INC.

Phages for a healthier world

MANSFIELD, United States · Founded 2019 · $4.3M raised

Biotech

Healthcare

Headquarters: MANSFIELD, Massachusetts
Employees: 1–10
Founded: 2019
Business Model: B2G

Website: phageproinc.com
Total Funding: $4.3M
Last Round: $1.0M Venture RoundJan 2025
Rounds: 3

About

PhagePro is an early-stage biotechnology company developing bacteriophage-based therapeutics to combat antibiotic resistance in the world's most vulnerable communities. Its lead program, ProphaLytic-Vc, targets cholera prevention using a shelf-stable, easy-to-administer phage therapeutic currently advancing toward first-in-human clinical studies.

Summary

PHAGEPRO, INC. is a Biotech company based in MANSFIELD, United States, founded in 2019. It has raised $4.3M in total across 3 rounds, most recently a $1.0M Venture Round round in Jan 2025. Investors include National Institutes of Health.